A. Evans

1.1k total citations
15 papers, 882 citations indexed

About

A. Evans is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, A. Evans has authored 15 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Clinical Biochemistry. Recurrent topics in A. Evans's work include Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (4 papers). A. Evans is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (4 papers). A. Evans collaborates with scholars based in United States. A. Evans's co-authors include Eileen Graffunder, Thomas P. Lodise, Kathleen A. Stellrecht, Jeffrey Graves, Ben M. Lomaestro, Richard A. Venezia, Karen E. Preston, Janet P. Haas, Elaine Larson and Susan M. Harrington and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Journal of Food Protection.

In The Last Decade

A. Evans

14 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Evans United States 13 576 437 223 191 185 15 882
Helen T. Fernandez United States 19 417 0.7× 299 0.7× 242 1.1× 170 0.9× 141 0.8× 26 865
M. Leticia McElmeel United States 12 511 0.9× 360 0.8× 248 1.1× 143 0.7× 231 1.2× 23 896
Deborah Ashcraft United States 16 379 0.7× 292 0.7× 223 1.0× 257 1.3× 364 2.0× 30 915
Matthew G. Stilwell United States 15 457 0.8× 327 0.7× 270 1.2× 334 1.7× 401 2.2× 20 1.0k
Molly E. Steed United States 18 650 1.1× 363 0.8× 341 1.5× 315 1.6× 284 1.5× 29 959
Carmen Betriú Spain 20 451 0.8× 331 0.8× 406 1.8× 259 1.4× 323 1.7× 55 1.1k
Patricia A. Hogan United States 17 826 1.4× 525 1.2× 312 1.4× 185 1.0× 309 1.7× 24 1.2k
Rebecca Hutton‐Thomas United States 11 847 1.5× 432 1.0× 251 1.1× 88 0.5× 266 1.4× 12 1.1k
Abdalhamid M Lagnf United States 18 468 0.8× 343 0.8× 317 1.4× 307 1.6× 366 2.0× 43 937
Sharon A. Crawford United States 13 502 0.9× 367 0.8× 226 1.0× 156 0.8× 195 1.1× 27 852

Countries citing papers authored by A. Evans

Since Specialization
Citations

This map shows the geographic impact of A. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Evans more than expected).

Fields of papers citing papers by A. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Evans. The network helps show where A. Evans may publish in the future.

Co-authorship network of co-authors of A. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of A. Evans. A scholar is included among the top collaborators of A. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Evans. A. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Evans, A., et al.. (2014). Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review. Journal of Antimicrobial Chemotherapy. 69(10). 2606–2610. 28 indexed citations
3.
Lodise, Thomas P., George L. Drusano, Victoria Lazariu, et al.. (2014). Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin . Journal of Antimicrobial Chemotherapy. 69(9). 2547–2555. 3 indexed citations
4.
Patel, Nimish, Susan M. Harrington, Benjamin K.P. Woo, et al.. (2011). Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 66(7). 1600–1608. 56 indexed citations
5.
Patel, Nimish, Salvatore Ferro, Machaon Bonafede, et al.. (2009). Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(12). 5141–5144. 28 indexed citations
6.
Lodise, Thomas P., Jeffrey Graves, A. Evans, et al.. (2008). Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin. Antimicrobial Agents and Chemotherapy. 52(9). 3315–3320. 457 indexed citations
7.
Lodise, Thomas P., Chris D. Miller, Jeffrey Graves, et al.. (2008). Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 62(5). 1138–1141. 60 indexed citations
8.
Graffunder, Eileen, Karen E. Preston, A. Evans, & Richard A. Venezia. (2005). Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. Journal of Antimicrobial Chemotherapy. 56(1). 139–145. 66 indexed citations
9.
Haas, Janet P., A. Evans, Karen E. Preston, & Elaine Larson. (2005). Risk factors for surgical site infection after cardiac surgery: The role of endogenous flora. Heart & Lung. 34(2). 108–114. 36 indexed citations
10.
Sauders, Brian D., Brian Currie, A. Evans, et al.. (2005). Low Prevalence of Listeria monocytogenes in Human Stool. Journal of Food Protection. 68(1). 178–181. 31 indexed citations
11.
Graham, Heather, Gail Feenstra, A. Evans, & Sheri Zidenberg-­Cherr. (2004). Davis school program supports life-long healthy eating habits in children. California Agriculture. 58(4). 200–205. 31 indexed citations
12.
Preston, Karen E., Eileen Graffunder, A. Evans, & Richard A. Venezia. (2003). Survey of Plasmid-Associated Genetic Markers in Enterobacteriaceae with Reduced Susceptibilities to Cephalosporins. Antimicrobial Agents and Chemotherapy. 47(7). 2179–2185. 18 indexed citations
13.
Evans, A., et al.. (2000). Vancomycin and Oxacillin Synergy for Methicillin-Resistant Staphylococci. Antimicrobial Agents and Chemotherapy. 44(5). 1394–1396. 43 indexed citations
14.
Evans, A., et al.. (1998). Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci. European Journal of Clinical Microbiology & Infectious Diseases. 17(3). 143–150. 13 indexed citations
15.
Evans, A., et al.. (1996). Use of human factors computer modeling to predict locations and settings for crew aids used in extravehicular activity on an International Space Station assembly mission. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 40(24). 1254–1254.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026